Onward Medical NV ONWD

BRU: ONWD | ISIN: NL0015000HT4 24/12/2025

4,205 EUR (+0,12%)

(+0,12%) 24/12/2025

Grafiek Onward Medical NV

Grafiek Onward Medical NV

1 dag1d 0,12%
1 week1w 0,60%
1 maand1m -4,54%
3 maanden3m -18,98%
6 maanden6m -5,40%
1 jaar1j -23,27%
5 jaar5j -67,02%

Adviezen van analisten

Koersdoel

10,50 EUR

+149,70%

Consensus

Kopen

Verdeling adviezen

Onward Medical NV in het nieuws

Toon enkel gratis nieuws

24 november 2025 · ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025 · Persbericht

17 november 2025 · ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use · Persbericht

28 oktober 2025 · ONWARD Medical Publishes Closing of Bookbuild Offering · Persbericht

24 oktober 2025 · ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase · Persbericht

22 oktober 2025 · ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million · Persbericht

13 oktober 2025 · ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States · Persbericht

8 oktober 2025 · Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20 · Persbericht

8 oktober 2025 · Portzamparc – Groupe BNP Paribas initie la couverture d’ONWARD Medical avec une recommandation d’Achat et un objectif de cours de 10,20 EUR · Persbericht

18 september 2025 · Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy · Persbericht

8 september 2025 · ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe